In a year featuring high-profile rejections and Covid-19-related inspection delays, the number of new drug approvals might have been expected to decline. Not so. Despite everything that happened in 2020, there were actually more US green lights last year than in 2019.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,